Pedersen, S.; Nielsen, M.Ø.; Donia, M.; Svane, I.M.; Zerahn, B.; Ellebaek, E.
Real-World Cardiotoxicity in Metastatic Melanoma Patients Treated with Encorafenib and Binimetinib. Cancers 2024, 16, 2945.
https://doi.org/10.3390/cancers16172945
AMA Style
Pedersen S, Nielsen MØ, Donia M, Svane IM, Zerahn B, Ellebaek E.
Real-World Cardiotoxicity in Metastatic Melanoma Patients Treated with Encorafenib and Binimetinib. Cancers. 2024; 16(17):2945.
https://doi.org/10.3390/cancers16172945
Chicago/Turabian Style
Pedersen, Sidsel, Marc Østergaard Nielsen, Marco Donia, Inge Marie Svane, Bo Zerahn, and Eva Ellebaek.
2024. "Real-World Cardiotoxicity in Metastatic Melanoma Patients Treated with Encorafenib and Binimetinib" Cancers 16, no. 17: 2945.
https://doi.org/10.3390/cancers16172945
APA Style
Pedersen, S., Nielsen, M. Ø., Donia, M., Svane, I. M., Zerahn, B., & Ellebaek, E.
(2024). Real-World Cardiotoxicity in Metastatic Melanoma Patients Treated with Encorafenib and Binimetinib. Cancers, 16(17), 2945.
https://doi.org/10.3390/cancers16172945